Josef Schoell |
jsc*****@caratherapeutics.com
|
Cara Therapeutics |
CFO |
Biotechnology Research |
Shelton, CT, US |
|
Rob Spencer |
rsp*****@caratherapeutics.com
|
Cara Therapeutics |
Vice President, Research And Development |
Biotechnology Research |
Stamford, CT, US |
|
Rick Makara |
rma****@caratherapeutics.com
|
Cara Therapeutics |
Vice President, Head of Accounting and Controller |
Biotechnology Research |
Stamford, CT, US |
|
Joana Goncalves |
jgo*******@caratherapeutics.com
|
Cara Therapeutics |
Chief Medical Officer |
Biotechnology Research |
New York, NY, US |
|
Iris Francesconi |
ifr*********@caratherapeutics.com
|
Cara Therapeutics |
Chief Strategy Officer and Head of Investor Relations |
Biotechnology Research |
New York, NY, US |
|
Frederique Menzaghi |
fme******@caratherapeutics.com
|
Cara Therapeutics |
|
Biotechnology Research |
Shelton, CT, US |
|
Kristine Nograles |
kno******@caratherapeutics.com
|
Cara Therapeutics |
|
Biotechnology Research |
Warren, NJ, US |
|
Mel Hayes |
mha***@fulcrumtx.com
|
fulcrumtx.com |
Chief Operating Officer |
|
Boston, MA, US |
|
Kim Hazen |
kha***@fulcrumtx.com
|
fulcrumtx.com |
Chief People Officer |
|
Cambridge, MA, US |
|
Helge Reisch |
hre****@fulcrumtx.com
|
fulcrumtx.com |
Vice President Drug Substance Process Development |
|
Cambridge, MA, US |
|